https://ph-ksp.com/impaired-bone-morphogenetic-protein-receptor-2-bmpr2-signalling-across-pulmonary-hypertension-subgroups-a-multicentre-study-european-respiratory-journal-open-research-2026/ 2026-08-11T11:37:48Z PULMONARY HYPERTENSION en Multicentre study explores impaired bone morphogenetic protein receptor 2 (BMPR2) signalling across pulmonary hypertension subgroups, European Respiratory Journal Open Research 2026 2026-08-11T07:38:49Z Blog https://ph-ksp.com/tenax-therapeutics-announces-results-from-phase-3-level-trial-of-tnx-103-in-patients-with-pulmonary-hypertension-associated-with-heart-failure-with-preserved-ejection-fraction-ph-hfpef-august-10-20/ 2026-08-11T07:24:34Z PULMONARY HYPERTENSION en Tenax Therapeutics announces results from phase 3 LEVEL trial of TNX-103 in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction, PH-HFpEF, August 10, 2026 2026-08-11T07:04:40Z Blog